NCT03296358 is a NA clinical trial of IV Dexamethasone in Urticaria, sponsored by Chulalongkorn University.

Who is sponsoring NCT03296358?

NCT03296358 is sponsored by Chulalongkorn University.

What drugs are being tested in NCT03296358?

Interventions in NCT03296358: IV Dexamethasone, Oral prednisolone.

What condition does NCT03296358 study?

NCT03296358 studies Urticaria, Allergy.

Is NCT03296358 still recruiting?

NCT03296358 is currently completed. Last updated 11 February 2020.

Last reviewed 2020-02-11 · How we verify

NCT03296358

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.

Completed NA Last updated 11 February 2020

What this trial tests

NA trial testing IV Dexamethasone in Urticaria in 75 participants. Completed in 31 October 2019.

Timeline

1 October 2017

Primary endpoint
31 October 2019

31 October 2019

Quick facts

Lead sponsor	Chulalongkorn University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	75
Start date	1 October 2017
Primary completion	31 October 2019
Estimated completion	31 October 2019
Sites	1 location across Thailand

Drugs / interventions tested

IV Dexamethasone — full drug profile →
Oral prednisolone

Conditions studied

Urticaria — all drugs for Urticaria →
Allergy — all drugs for Allergy →

Sponsor

Chulalongkorn University

Who can join

Adults 18 to 50, any sex, with Urticaria or Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, double-blinded, controlled trial of adding a short burst of corticosteroid to the conventional treatment of H1 antihistamines

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of IV Dexamethasone

Trials testing the same drug.

NCT04513184 — Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 · Phase 2 · completed

Other Chulalongkorn University trials

Trials by the same sponsor.

NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03296358 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
Last refreshed: 11 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03296358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing